Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_91b17bab20816c25a18e521b2f564850 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb9c6b40161bafe7bd55f0b4defcea04 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-50 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1735 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-177 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4727 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-09 |
filingDate |
2010-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2013-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_276a1e3229e9d4ee1279ef65a933e254 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1d93364732ab83512748e42f6f71ad1 |
publicationDate |
2013-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2010253834-B2 |
titleOfInvention |
Inhibition 0f inflammation using antagonists of MUC1 |
abstract |
The invention provides for peptides from the MUCl cytoplasmic domain and methods of use therefor. These peptides can inhibit MUCl oligomerization, inhibit the interaction of MUCl with NF -KB or a STAT, and block inflammatory response mediated by NF-κB or STAT signaling. |
priorityDate |
2009-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |